Effect of Moderate Alcohol Consumption to Cognitive Functioning After Roux-en Y Gastric Bypass
NCT ID: NCT02380950
Last Updated: 2015-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Methods: We included 28 females (12 gastric bypass patients, 8 obese and 8 normal weight subjects) in the study. Each participant had to drink 250 ml white wine. Directly before, 10-30 min after and 45-65 min after wine consumption cognitive functions were tested by test battery for attentional performance (TAP) from Zimmermann and Fimm. During the whole examination breath-alcohol-contents (BACs) were measured every 5 minutes with breathalyser "Dräger Alcotest 7510".
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol Oxidation
NCT00285909
Moderate Alcohol Consumption, Glucose Metabolism and Gastric Emptying
NCT00523861
Effects of Red Wine on Cardiovascular Risk Factors in Humans
NCT00954434
The Effects of Alcohol Consumption on Central Adiposity
NCT03521817
Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly
NCT02822911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
250 ml alcohol consumption
Each participant had to drink 250 ml white wine. Directly before, 10-30 min after and 45-65 min after wine consumption cognitive functions were tested by test battery for attentional performance (TAP) from Zimmermann and Fimm. During the whole examination breath-alcohol-contents (BACs) were measured every 5 minutes with breathalyser "Dräger Alcotest 7510".
250 ml alcohol consumption
Each participant had to drink 250 ml white wine. Directly before, 10-30 min after and 45-65 min after wine consumption cognitive functions were tested by test battery for attentional performance (TAP) from Zimmermann and Fimm. During the whole examination breath-alcohol-contents (BACs) were measured every 5 minutes with breathalyser "Dräger Alcotest 7510".
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
250 ml alcohol consumption
Each participant had to drink 250 ml white wine. Directly before, 10-30 min after and 45-65 min after wine consumption cognitive functions were tested by test battery for attentional performance (TAP) from Zimmermann and Fimm. During the whole examination breath-alcohol-contents (BACs) were measured every 5 minutes with breathalyser "Dräger Alcotest 7510".
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women
* preOP BMI \>35 kg/m²
* time since bariatric surgery \> 1 year
* age 18-60 years
* moderate drinking habits
obese group:
* women
* BMI \>35 kg/m²
* age 18-60 years
* moderate drinking habits
normal weight group:
* women
* BMI 18.5 - 25 kg/m²
* age 18-60 years
* moderate drinking habits
Exclusion Criteria
* patient does not drink wine
* usage of psychotropic drugs
* alcoholic
* pregnancy
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
eSwiss Medical & Surgical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernd Schultes
Prof. Dr. med. Bernd Schultes
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKSG 13/046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.